8. Cancers can shed cells that circulate in the bloodstream at extremely low levels. This technology finds them by passing a blood sample through a microchip coated with antibodies that bind only to the cancer cells. 

癌症能掉落下细胞，在血液里以极低的水平循环。这种技术通过让血液样本经过涂有只束缚癌细胞抗体的微芯片，来发现癌细胞。

9. The test can recognize a single cancer cell among a billion normal ones. 

这种化验能识别在10亿正常细胞中的单个癌细胞。

10. "It would be most helpful for patients with prostate, bladder, colon, kidney and lung cancer, in addition to breast cancers. In many ways, it serves as a liquid biopsy."

这种实验，除了对乳腺癌以外，还对前列腺癌、膀胱癌、结肠癌、肾癌、肺癌病人会极为有用。这种实验在很多方面起到了液体活组织检查的作用。

11. In addition to finding recurrences sooner, the test may allow doctors to examine the cancer cell itself and tailor therapies to a particular patient. 

除了更早地发现癌症复发以外，这种实验也可以使医生检查癌细胞本身，并且使治疗适合特定的病人。

12. Five sites across the country are beginning to use the new test on patients. The research is supported by a $15 million grant from "Stand Up to Cancer."

全国的5个地方开始在病人使用这种新实验。这项研究得到“抵抗癌症”基金的1500万美金的资助。

13. "If we only had a way of measuring cancers as they are being treated, seeing how they respond relatively quickly and adjusting our treatment depending on how the treatment responds, then it would be a different day for treating cancer." 

如果我们有了如同癌症得到治疗的检验方法，明白这样的方法如何较快地对癌症起作用并且根据治疗的作用如何来调整治疗，那么，治疗癌症将会是不同了。

14. If all goes well, the test is expected to become widely available in three to five years. 

如果一切进展顺利，预计这种化验在3-5年后为广泛所用。

责任编辑：admin